Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ --Â A recently published five-year pharmacovigilance study confirms…
PSP Investments continues track record of strong returns and portfolio resilience with a 12.6% return in fiscal 2025, net assets approach $300 billion
Five and 10-year net annualized returns of 10.6% and 8.2%.$31.9 billion in…
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more…